Shandong Provincial Hospital
Clinical trials sponsored by Shandong Provincial Hospital, explained in plain language.
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests a new approach for people with locally advanced stomach or gastroesophageal junction cancer. Before surgery, patients receive a combination of low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX). The goal is to see if this treatment ca…
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study tests two different radiation schedules (short-course vs long-course) given together with an immunotherapy drug (Adebrelimab) and chemotherapy before surgery for people with locally advanced rectal cancer. About 208 participants will be randomly assigned to one of the …
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New combo may turn inoperable esophageal cancer into operable disease
Disease control Recruiting nowThis study tests whether a combination of tislelizumab (an immunotherapy) and chemotherapy can shrink advanced esophageal cancer enough to allow surgery. About 30 adults with initially inoperable tumors will receive the treatment for 2-4 cycles. The main goal is to see how many b…
Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug cocktail aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding a new immunotherapy combination (iparomlimab and tuvonralimab) to standard chemotherapy can better shrink locally advanced stomach or gastroesophageal junction cancer before surgery. About 96 adults with stage T3N+ or T4a cancer that hasn't spread …
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Nature tourism as a new antidepressant?
Symptom relief Recruiting nowThis study explores whether nature-based tourism activities can improve symptoms in people with major depressive disorder. Researchers will measure changes in mood, thinking, and social function in 86 adults aged 18-59. The goal is to see if time in nature can be a helpful additi…
Phase: NA • Sponsor: Shandong Provincial Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Heart MRI model could predict deadly risks in DCM patients
Knowledge-focused Recruiting nowThis study aims to create a tool that helps doctors predict which patients with dilated cardiomyopathy (a condition where the heart becomes enlarged and weak) are at highest risk for serious problems like heart failure, dangerous heart rhythms, or sudden cardiac death. Researcher…
Sponsor: Shandong Provincial Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC